1. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved
    Yasuhiro Watanabe et al, 2020, Journal of Atherosclerosis and Thrombosis CrossRef
  2. Fatty acid desaturase 2 is up-regulated by the treatment with statin through geranylgeranyl pyrophosphate-dependent Rho kinase pathway in HepG2 cells
    Shou Tanaka et al, 2019, Scientific Reports CrossRef
  3. Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
    Rosa Lundbye Allesøe et al, 2023, Nature Biotechnology CrossRef
  4. A common variant in ARHGEF10 alters delta-6 desaturase activity and influence susceptibility to hypertriglyceridemia
    Juan de Toro-Martín et al, 2018, Journal of Clinical Lipidology CrossRef
  5. A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology
    Xiangyu Wang et al, 2023, European Journal of Medical Research CrossRef
  6. Identification of a functional FADS1 3′UTR variant associated with erythrocyte n-6 polyunsaturated fatty acids levels
    Xavier Hermant et al, 2018, Journal of Clinical Lipidology CrossRef
  7. Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome
    Shusuke Yagi et al, 2019, Journal of Atherosclerosis and Thrombosis CrossRef
  8. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats
    Yan Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  9. Bioactive Lipids as Mediators of the Beneficial Actions of Statins
    Undurti N. Das, 2019, Journal of Cardiovascular Pharmacology CrossRef
  10. Lipid Profiling of Serum and Lipoprotein Fractions in Response to Pitavastatin Using an Animal Model of Familial Hypercholesterolemia
    Hiroaki Takeda et al, 2020, Journal of Proteome Research CrossRef
  11. Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art
    Yasuhiro Watanabe et al, 2021, Expert Review of Clinical Pharmacology CrossRef